We Like Vitamins, Lycopene 50 mg, Dietary Supplement, 200 Capsules
Published April 22, 2020 · Recall initiated: March 27, 2020
Summary
FDA records food Class III recall F-0923-2020, published April 22, 2020 and initiated March 27, 2020. Recalling firm: CT Health Solutions, LLC; Status: Terminated; Reported quantity: 1500 Bottles; Lot: Dec/2023, Lot# 02121902. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Due to different color of powder in capsules. Firm's evaluation determined product low potency.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- CT Health Solutions, LLC
- Distributor
- Product was distributed to 1 consignee in Michigan (Domestic distribution only)
- Lot
- Dec/2023, Lot# 02121902
- Risk classification
- Class III
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDARoasted/Salted Deluxe Mixed Nuts; Net Wt. 10 oz./284 g, Clear plastic container UPC 65143370994 Cashews,April 22, 2020
- FDASPICE (JWH-018) CC443April 22, 2020
- FDASunshine Spice DRIED SHRI SKIN TRI TRI, Weight (lb) 0.215April 22, 2020
- FDAThe CF-70 instrument (product code: LXG; Regulation Number: 862.2050) receives magazines containing stainedApril 22, 2020
- FDADION DION DRIED MUSHROOMS, Product Origin from Haiti, Net Wt. 1/4 ozApril 22, 2020
- FDAVACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.April 22, 2020
Questions about this recall
Was We Like Vitamins, Lycopene 50 mg, Dietary Supplement, 200 Capsules recalled?
Yes. FDA published recall F-0923-2020 on April 22, 2020. Reported hazard: Due to different color of powder in capsules. Firm's evaluation determined product low potency.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit